Both in Pharmaceuticals
Verrica Pharmaceuticals vs Clene
Over the past year VRCA returned −3.9% and CLNN returned −57.0%; their daily moves had a correlation of 0.06.
VRCA −3.9% CLNN −57.0%Growth of $1, one year, split-adjusted
| Metric | VRCA | CLNN |
|---|---|---|
| Price | $3.48 | $4.03 |
| Market cap | $59.8M | $57.3M |
| Today | +0.29% | +1.51% |
| 1 month | −22.0% | −1.7% |
| 6 months | −47.1% | −30.5% |
| Year to date | −58.1% | −31.3% |
| 1 year | −7.4% | −52.6% |
| Revenue growth (YoY) | −53.8% | +233.3% |
| Gross margin | 85.0% | 60.0% |
| Net margin | −224.4% | −14915.6% |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | 290.8× |
| Net cash | $9.8M | -$9.1M |
| Dividend yield | — | — |
| Volatility (60d) | 63.1% | 81.6% |
| Short % of float | 2.5% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).